NR4A1 and breast cancer: Noteworthy, the hypercoagulability did not seem to depend on hormone receptor status, as the estimated associations between breast cancer and the hemostatic plasma markers were not significantly different between hormone receptor negative or triple negative patients and patients with other subtypes.